NASDAQ: PPCB
Propanc Biopharma Inc Stock Ownership - Who owns Propanc Biopharma?

Insider buying vs selling

Have Propanc Biopharma Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PPCB insiders and whales buy or sell their stock.

PPCB Shareholders

What type of owners hold Propanc Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Jane Street Group LLC0.01%56$108.70Institution
Stonex Group Inc0.00%11$21.35Institution
Bank Of Montreal0.00%10$19.41Institution
Caitong International Asset Management Co Ltd0.00%0$0.00Institution
Jpmorgan Chase Co0.00%0$0.00Institution

1 of 1

PPCB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PPCB0.01%0.00%
ELAB0.00%100.00%
KAPA0.00%100.00%
CLDI0.00%100.00%Net Selling
DCOY0.00%100.00%Net Buying

Propanc Biopharma Stock Ownership FAQ

Who owns Propanc Biopharma?

Propanc Biopharma (NASDAQ: PPCB) is owned by 0.01% institutional shareholders, 0.00% Propanc Biopharma insiders, and 99.99% retail investors. Jane Street Group LLC is the largest individual Propanc Biopharma shareholder, owning 56.00 shares representing 0.01% of the company. Jane Street Group LLC's Propanc Biopharma shares are currently valued at $105.84.

If you're new to stock investing, here's how to buy Propanc Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.